RBC Europe’s Amgen AMGN Stock Holding History

RBC Europe’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$262K	Hold	1,077	–	–	0.01%	182
2022 Q1	$260K	Hold	1,077	–	–	0.01%	202
2021 Q4	$242K	Buy	1,077 +76	+8%	+$16K	0.01%	209
2021 Q3	$213K	Sell	1,001 -70	-7%	-$16.1K	0.01%	289
2021 Q2	$261K	Sell	1,071 -27	-2%	-$6.64K	0.01%	277
2021 Q1	$273K	Sell	1,098 -115	-9%	-$27.4K	0.01%	255
2020 Q4	$279K	Buy	1,213 +319	+36%	+$73.5K	0.02%	236
2020 Q3	$227K	Buy	894 +115	+15%	+$28.5K	0.02%	238
2020 Q2	$184K	Buy	779 +281	+56%	+$64.1K	0.01%	255
2020 Q1	$101K	Hold	498	–	–	0.01%	294
2019 Q4	$120K	Hold	498	–	–	0.01%	314
2019 Q3	$96.4K	Sell	498 -198	-28%	-$38K	0.01%	340
2019 Q2	$128K	Hold	696	–	–	0.01%	309
2019 Q1	$132K	Buy	696 +295	+74%	+$56.3K	0.01%	288
2018 Q4	$78.1K	Hold	401	–	–	0.01%	352
2018 Q3	$83.1K	Sell	401 -91	-18%	-$17.9K	0.01%	383
2018 Q2	$90.8K	Sell	492 -100	-17%	-$17.7K	0.01%	361
2018 Q1	$101K	Sell	592 -495	-46%	-$90.9K	0.01%	341
2017 Q4	$189K	Hold	1,087	–	–	0.02%	255
2017 Q3	$203K	Buy	+1,087	New	+$193K	0.03%	243

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RBC Europe's AMGN Position: Q2 2022 in Review

RBC Europe held its Amgen (AMGN) position steady in Q2 2022 at 1,077 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #182.

RBC Europe first reported a position in AMGN in Q3 2017 and has held it in 20 quarters since. The position peaked at $279K in Q4 2020. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

RBC Europe held 1,077 shares of Amgen worth $262K as of Q2 2022.
RBC Europe left its Amgen share count unchanged in Q2 2022.
Amgen made up 0.01% of RBC Europe's portfolio in Q2 2022, its #182 holding.
RBC Europe first reported a position in Amgen in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Amgen position peaked at $279K in Q4 2020.
2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.